 Beneficial effects alpha activity myocardial stunning dogs study adrenoceptor activity beneficial dysfunction reperfusion brief period ischemia stunned myocardium open-chest dogs Contractile dysfunction fractional shortening FS hours onset reperfusion minutes complete occlusion left anterior coronary artery Pretreatment prazosin micrograms/kg/min i.c contractile dysfunction untreated condition versus prazosin treatment alpha agonists methoxamine microgram/kg/min i.c norepinephrine microgram/kg/min i.c rauwolscine propranolol contractile dysfunction FS methoxamine-treated group untreated group FS norepinephrine-treated group versus propranolol group adenosine release hyperemic coronary flow response early reperfusion period prazosin-treated group alpha stimulation groups results beneficial effects alpha activity due enhanced release adenosine cause-effect relation extent adenosine release contractile dysfunction reperfusion adenosine receptors methoxamine-treated group treatment FS beneficial effect enhanced adenosine release alpha stimulation Furthermore prazosin-treated group adenosine micrograms/kg/min left anterior coronary artery minutes hours onset reperfusion hyperemic coronary flow contractile dysfunction FS levels alpha stimulation groups treatment papaverine deleterious effects prazosin fact comparable hyperemic flow lactate production minutes onset reperfusion contractile function prazosin-treated methoxamine-treated groups untreated group electron microscopic examination irreversible myocardial injury pharmacological interventions alpha activity magnitude myocardial stunning cellular mechanism due enhanced adenosine release alpha activity ABSTRACT TRUNCATED AT WORDS